Cite

HARVARD Citation

    Fleseriu, M. et al. (2019). Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial. Lancet. 7 (11), pp. 855-865. [Online]. 
  
Back to record